Li Tang

12.0k total citations · 6 hit papers
187 papers, 8.8k citations indexed

About

Li Tang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Li Tang has authored 187 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 42 papers in Oncology and 38 papers in Immunology. Recurrent topics in Li Tang's work include Nanoparticle-Based Drug Delivery (25 papers), Microbial Natural Products and Biosynthesis (20 papers) and Immunotherapy and Immune Responses (20 papers). Li Tang is often cited by papers focused on Nanoparticle-Based Drug Delivery (25 papers), Microbial Natural Products and Biosynthesis (20 papers) and Immunotherapy and Immune Responses (20 papers). Li Tang collaborates with scholars based in China, United States and Switzerland. Li Tang's co-authors include Jianjun Cheng, Timothy M. Fan, Qian Yin, Darrell J. Irvine, C. Richard Hutchinson, Yuqing Xie, Kewen Lei, Rong Tong, Luke B. Borst and Yugang Guo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Chemical Society Reviews.

In The Last Decade

Li Tang

185 papers receiving 8.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Investigating the optimal size of anticancer nanomedicine

2014 563 citations Li Tang et al. profile →
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

2018 542 citations Li Tang, Yiran Zheng et al. profile →
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

2020 370 citations Min Gao, Li Tang et al. profile →
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy

2021 176 citations Kewen Lei, Armand Kurum et al. Nature Biomedical Engineering profile →
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases

2024 144 citations Bing Feng, Yuqing Xie et al. profile →
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases

2024 45 citations Valentin Gensbittel, Lucia Bonati et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li Tang China	48	3.6k	2.4k	1.9k	1.8k	1.4k	187	8.8k
Mahitosh Mandal India	64	6.0k 1.7×	1.7k 0.7×	1.7k 0.9×	812 0.4×	2.5k 1.8×	302	12.6k
Mahmoud Reza Jaafari Iran	60	5.0k 1.4×	2.2k 0.9×	2.9k 1.5×	2.3k 1.3×	1.2k 0.9×	387	11.8k
Nosratollah Zarghami Iran	56	5.6k 1.6×	3.0k 1.2×	3.7k 1.9×	825 0.5×	1.1k 0.8×	375	13.8k
Yu Zhang China	57	3.6k 1.0×	3.2k 1.3×	3.4k 1.8×	1.7k 1.0×	1.6k 1.2×	508	12.5k
Ning Zhang China	58	5.3k 1.5×	2.2k 0.9×	1.3k 0.7×	1.9k 1.0×	1.9k 1.4×	327	11.2k
Subhash C. Chauhan United States	56	4.6k 1.3×	1.4k 0.6×	2.2k 1.2×	866 0.5×	1.5k 1.1×	181	9.7k
Man Li China	56	3.8k 1.1×	2.2k 0.9×	1.5k 0.8×	1.8k 1.0×	1.9k 1.4×	354	9.8k
Crispin R. Dass Australia	54	5.7k 1.6×	1.8k 0.7×	2.3k 1.2×	570 0.3×	1.7k 1.2×	223	11.5k
Na Zhang China	57	4.9k 1.4×	3.0k 1.2×	3.0k 1.6×	1.8k 1.0×	1.6k 1.2×	460	12.2k
Yadollah Omidi Iran	60	5.6k 1.6×	3.6k 1.5×	2.8k 1.4×	639 0.4×	863 0.6×	340	12.0k

Countries citing papers authored by Li Tang

Since Specialization

Citations

This map shows the geographic impact of Li Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Tang more than expected).

Fields of papers citing papers by Li Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Tang. The network helps show where Li Tang may publish in the future.

Co-authorship network of co-authors of Li Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Li Tang. A scholar is included among the top collaborators of Li Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Tang. Li Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Li, et al.. (2025). Mimicking the TCR immune synapse for improved CAR-T cell function. Cell Research. 35(8). 549–550. 2 indexed citations

Feng, Bing & Li Tang. (2024). A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response. Clinical and Translational Medicine. 15(1). e70154–e70154.

Feng, Bing, Rongrong Li, Weilin Li, & Li Tang. (2024). Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy. Cell Systems. 15(12). 1225–1244. 6 indexed citations

Gensbittel, Valentin, et al.. (2024). Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nature Nanotechnology. 19(3). 281–297. 45 indexed citations breakdown →

Hu, Xile, et al.. (2023). Smart chemistry for traceless release of anticancer therapeutics. Biomaterials. 303. 122353–122353. 14 indexed citations

Xie, Yuqing, Simon Van Herck, Sina Nassiri, et al.. (2021). Switchable immune modulator for tumor-specific activation of anticancer immunity. Science Advances. 7(37). eabg7291–eabg7291. 36 indexed citations

Lei, Kewen, Armand Kurum, Murat Kaynak, et al.. (2021). Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nature Biomedical Engineering. 5(12). 1411–1425. 176 indexed citations breakdown →

Bonati, Lucia & Li Tang. (2021). Cytokine engineering for targeted cancer immunotherapy. Current Opinion in Chemical Biology. 62. 43–52. 47 indexed citations

Gao, Min, Yuqing Xie, Kewen Lei, et al.. (2021). A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy. Advanced Therapeutics. 4(8). 56 indexed citations

10.

Silva, Joana G., Tania Wyss, Silvia A. Fuertes Marraco, et al.. (2020). Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity. 53(5). 985–1000.e11. 126 indexed citations

11.

Wei, Lixia, et al.. (2020). Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine. ACS Central Science. 6(3). 404–412. 51 indexed citations

12.

Lei, Kewen & Li Tang. (2020). T cell force-responsive delivery of anticancer drugs using mesoporous silica microparticles. Materials Horizons. 7(12). 3196–3200. 14 indexed citations

13.

Liu, Xueqiang, Lei Liu, Yanyan Liu, et al.. (2019). Extrinsic Fabry Perot interferometer fiber sensor for simultaneous measurement of hydrazine vapor and temperature. Sensors and Actuators A Physical. 292. 60–65. 6 indexed citations

14.

Loukogeorgakis, Stavros, Haiying Li, Li Tang, et al.. (2019). Donor cell engineering with GSK3 inhibitor–loaded nanoparticles enhances engraftment after in utero transplantation. Blood. 134(22). 1983–1995. 14 indexed citations

15.

Guo, Yugang & Li Tang. (2019). A Magnetic Nanovaccine Enhances Cancer Immunotherapy. ACS Central Science. 5(5). 747–749. 9 indexed citations

16.

Xie, Yuqing, Lixia Wei, Yiran Zheng, et al.. (2019). Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells. Biomaterials Science. 7(4). 1345–1357. 79 indexed citations

17.

Chen, Shanshan, Juan Deng, Chao Huang, et al.. (2018). Endocannabinoid hydrolase and cannabinoid receptor 1 are involved in the regulation of hypothalamus-pituitary-adrenal axis in type 2 diabetes. Metabolic Brain Disease. 33(5). 1483–1492. 8 indexed citations

18.

Tang, Li, David Cipolla, Thomas Rades, & Ben J. Boyd. (2018). Drug nanocrystallisation within liposomes. Journal of Controlled Release. 288. 96–110. 111 indexed citations

19.

Chen, Kejie, Xi Peng, Jing Fang, et al.. (2014). Effects of Dietary Selenium on Histopathological Changes and T Cells of Spleen in Broilers Exposed to Aflatoxin B1. International Journal of Environmental Research and Public Health. 11(2). 1904–1913. 46 indexed citations

20.

Li, Ming, Weihua Li, Wen Shu, Yinhui Liu, & Li Tang. (2013). Effects of ceftriaxone‐induced intestinal dysbacteriosis on dendritic cells of small intestine in mice. Microbiology and Immunology. 57(8). 561–568. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact